Women Veterans and Sleep:
Military Sexual Trauma, Hormones, and the Visibility Gap
MST affects 1 in 4 women veterans and is the primary driver of their sleep disorders, what Travis 2024 shows, why standard insomnia treatment fails, and how to get the right care.
Key Takeaways
- MST affects 1 in 4 women veterans; MST survivors are 7.25× more likely to develop PTSD, the primary driver of women veterans’ sleep disorders, not combat exposure.
- Travis et al. 2024 (n=232): military sexual assault independently predicted clinically significant insomnia (OR 3.18); 73% reported MST and 36% met moderate-to-severe insomnia criteria.
- OSA in women presents atypically: insomnia, fatigue, and depression rather than snoring. And MST history is independently linked to elevated OSA risk.
- After CPT for MST-related PTSD: 100% had clinically significant sleep disturbance at baseline, 89% retained it post-treatment. CBT-I and IRT must be concurrent, not afterthoughts.
The MST-Sleep Cascade
How MST produces sleep disorders
Military sexual trauma triggers the same HPA-LC hyperactivation cascade as combat trauma, elevated cortisol, elevated norepinephrine, amygdala sensitization, impaired prefrontal regulation. The resulting PTSD has identical sleep disruption features: difficulty initiating sleep, nightmares, hypervigilance at night, non-restorative sleep.
The specific features of MST-related PTSD differ from combat-related PTSD in one critical dimension: the perpetrator was a colleague or superior in a context where official channels were often inaccessible or actively hostile. This produces institutional betrayal trauma, an additional layer that persists in healthcare encounters. A woman veteran with MST-related PTSD seeking sleep care at the VA is returning to a system that represents, in many ways, the institutional context of her original trauma.
MST and sleep apnea
The Gibson 2019 finding
The 2019 Gibson VA San Francisco study[2] was the first to link MST specifically to sleep apnea risk in older women veterans, an association not accounted for by standard OSA risk factors such as obesity and neck circumference alone.
How female OSA is missed
Women with OSA more often present with insomnia, fatigue, and depression rather than snoring, symptoms that overlap completely with PTSD. VA screening tools calibrated to male presentation miss female-pattern OSA at high rates, often misattributing the symptoms to the primary trauma diagnosis.
The compound diagnostic trap
MST survivors treated for “PTSD insomnia” for years may have undiagnosed OSA as a complicating or contributing factor. Treating PTSD alone while OSA goes undetected leaves a second major sleep disorder perpetuating the symptoms.
Who this applies to most
- Women veterans who have experienced MST: The most directly affected population; sleep disorders in this group are predominantly trauma-driven and require MST-informed clinical approaches at every step.
- Midlife and older women veterans: Travis 2024 data shows MST consequences persist across the lifespan and compound at menopause.
- Women veterans with treatment-resistant insomnia: If standard insomnia treatment has failed, an undertreated or undisclosed MST-PTSD foundation may be the explanation.
- VA providers treating women veterans: MST screening before sleep disorder treatment, not after; trauma-informed care throughout; lower threshold for concurrent nightmare and insomnia treatment.
The Evidence Base
Travis et al. 2024
The most directly relevant recent study: 232 midlife women veterans ages 45–64 enrolled in VA care in Northern California. Key findings: 73% reported MST; 36% met criteria[1] for moderate-to-severe insomnia; military sexual assault was independently associated with clinically significant insomnia (OR 3.18, 95% CI 1.72–5.88).[1] MST was also independently associated with vasomotor symptoms (hot flashes and night sweats) that add an additional sleep disruption mechanism at menopause.
CPT and persistent sleep disturbance
Levy et al. (2019, Military Medicine, n=72 veterans with MST-related PTSD) examined sleep disturbance before and after CPT. At baseline: 100% of participants had clinically significant sleep disturbance. At post-treatment: 89%.[3] The PTSD reduction from CPT did not predict sleep improvement. This finding, consistent with the broader PTSD-sleep literature, means that women veterans receiving trauma-focused treatment for MST-related PTSD will retain their sleep disorder at high rates without concurrent sleep-specific treatment.
OSA underdiagnosis
Women with OSA are consistently underdiagnosed because the condition presents differently than in men. VA screening tools calibrated to male presentation miss female-pattern OSA at high rates. MST history adds OSA risk through autonomic dysregulation and weight changes associated with trauma. The result: a woman veteran with MST-PTSD who also has OSA is likely being treated only for the PTSD while the OSA compounds her sleep disruption.
What the Evidence Doesn’t Say
Optimal treatment sequence. Whether trauma-focused treatment should precede, follow, or be concurrent with CBT-I and nightmare treatment for MST-related sleep disorders is not established by RCT evidence in this specific population.
MST disclosure rates and VA care outcomes. Most MST-related research includes only veterans who have disclosed MST. The substantial proportion who never disclose is, by definition, unrepresented, and may carry the highest treatment burden.
Menopause-specific interventions for women veterans with MST. Whether hormone therapy, non-hormonal vasomotor symptom treatment, or circadian interventions have specific utility in this population has not been directly studied.
Clinical Implications
| Application | Evidence | Strength | Notes |
|---|---|---|---|
| MST screen before or concurrent with sleep disorder assessment | MST is the primary driver of sleep disorders in women veterans; treating the sleep disorder without addressing MST context is clinically inadequate | Strong (epidemiological data) | VA mandatory MST screening policy exists; ensure it is applied before sleep medicine referral |
| Add concurrent CBT-I and nightmare treatment when providing trauma-focused PTSD care | CPT alone leaves 89% with clinically significant sleep disturbance at post-treatment | Moderate–strong (Levy 2019; VA/DoD CPG) | IRT plus CBT-I combination is appropriate when both nightmares and insomnia are present |
| Screen for OSA with polysomnography in treatment-refractory cases | Female-pattern OSA presents atypically; standard screening misses it; MST adds OSA risk | Moderate (Gibson 2019; OSA gender difference literature) | Do not rely on Epworth Sleepiness Scale alone for women with PTSD and insomnia |
| Create trauma-informed sleep medicine environments | Institutional betrayal trauma creates VA-specific clinical encounter barriers for MST survivors | Clinical practice | Explicitly acknowledge the trust dimension; offer female-identified providers when possible |
What Can You Do?
| How to Implement | Expected Benefit (and Why) | Evidence Strength | Context Notes |
|---|---|---|---|
| Request an MST-specialized care coordinator at your VA | |||
| Every VA facility has a designated MST Coordinator; ask the patient advocate or call the facility MST line | Accesses the specific care pathway designed for MST-related health issues, because general mental health intake may not trigger MST-specific protocols that improve clinical engagement and treatment access | Strong (VA policy) | The MST Coordinator can facilitate referrals to MST-specific PTSD and sleep care pathways |
| Explicitly connect your sleep disorder to MST in your VA documentation | |||
| At your next appointment: “I believe my insomnia and nightmares are connected to my MST history. I want this documented and I want to discuss MST-specific treatment options including IRT and CBT-I.” | Creates the documented connection that drives MST-specific care, because sleep disorders labeled as ‘primary insomnia’ without MST notation may not receive the trauma-informed concurrent treatment the evidence requires | Clinical practice | You have the right to request this documentation |
| Ask about OSA evaluation if standard insomnia treatment has not worked | |||
| Tell your provider: “I have had insomnia that has not responded to standard treatment. I want to be screened for sleep apnea, I know women present differently than men.” | Opens the OSA diagnostic pathway that MST risk elevation warrants, because female-pattern OSA mimics PTSD insomnia and is missed by standard screening calibrated to male presentation | Moderate (Gibson 2019; OSA gender literature) | Request polysomnography, not just the Epworth scale |
| Ask for concurrent nightmare and insomnia treatment simultaneously | |||
| Tell your mental health or sleep provider: “I know CPT for PTSD may not resolve my sleep disturbance. I want to address nightmares with IRT and insomnia with CBT-I concurrently, not sequentially.” | Prevents the wait-and-see approach that leaves 89% of CPT recipients with persistent sleep disorder, because the evidence shows trauma treatment does not carry over to sleep improvement, they require separate targeted interventions | Moderate–strong (Levy 2019; VA/DoD CPG) | Most VA facilities can deliver all three concurrently with explicit clinical planning |
How to Use AI With This Information
When to Work With a Professional
Women veterans with MST-related sleep disorders require MST-informed clinical care, not standard insomnia treatment. Seek MST Coordinator support at your VA facility and ask specifically for trauma-informed sleep medicine evaluation that includes nightmare disorder assessment, OSA screening, and CBT-I access.
FAQ’s
Do I have to disclose the MST details to get sleep treatment?
No. VA sleep medicine providers do not need the details of your MST to treat your sleep disorder. What is helpful is noting that your sleep symptoms are connected to a traumatic history, this context informs treatment choice without requiring disclosure.
Is VA care for MST-related conditions available even if I didn’t report the MST at the time?
Yes. VA policy does not require in-service documentation of MST to receive care or file a disability claim for related conditions. Mental health and sleep disorder care related to MST is available to any veteran who reports MST to their VA provider, regardless of in-service documentation.
REFERENCES
- Travis KJ et al. (2024). Military sexual trauma and menopause symptoms among midlife women veterans. J Gen Intern Med, 39(3), 411–417. doi:10.1007/s11606-023-08493-w
- Gibson CJ et al. (2019). MST as a risk factor for sleep apnea in older women veterans. VA Research report.
- Levy CF et al. (2019). CPT and sleep disturbance in MST-related PTSD. Mil Med, 184(9-10), e504–e509. doi:10.1093/milmed/usz059
- Kelly UA. (2021). Barriers to PTSD treatment-seeking by women veterans with MST. Nursing Outlook, 69(3), 458–470.
- Wilson LC. (2018)[5]. The prevalence of military sexual trauma: a meta-analysis. Trauma Violence Abuse, 19(5), 584–597.
- Department of Veterans Affairs. (2024). Women Veterans Report: The Journey to Mental Wellness. DAV Report.
- Chen JA et al. (2024). MST as a risk factor for treatment non-response in telehealth PTSD intervention. J Interpers Violence. doi:10.1177/08862605231216722
- Troxel WM et al. (2015). Sleep in the Military. RAND Corporation. RAND Health Quarterly, 5(2):19